Nrx Pharmaceuticals (NRXP) Stock
Small pharmaceutical company developing new drug treatments. Here's the price, business snapshot, and what's worth knowing about Nrx Pharmaceuticals in August 2026.
NRX Pharmaceuticals Inc (NRXP) is a small-cap pharmaceutical company with a market capitalisation of roughly $76.3 million. As with many firms in this sector, NRX may focus on developing or licensing drug candidates rather than generating large commercial revenues today. Investors should know that small-cap biopharma stocks are often driven by clinical or regulatory milestones, partnerships and fundraising activity, which can create sharp share price moves in either direction. Key considerations include the company’s cash runway, the stage of any programmes, intellectual property and potential partners. Because such companies typically carry higher operational and clinical risk, performance can be volatile and future returns are uncertain. This summary is for general educational purposes only and not personal investment advice; suitability depends on an investor’s time horizon, risk tolerance and financial situation.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying NRX Pharmaceuticals' stock, with a target price of $32.5 indicating strong potential growth.
Financial Health
NRX Pharmaceuticals is generating positive cash flow, indicating they have money coming in from operations.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Catalysts and Milestones
Clinical readouts, regulatory steps or partnership deals can move the stock materially, though outcomes are uncertain and may increase volatility.
Funding and Runway
Small biotechs often rely on capital markets or partners to fund development; check cash runway and potential dilution risks before investing.
Industry Context
Trends in regulation, competitor progress and licensing opportunities affect prospects, but therapeutic development timelines and outcomes can vary.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
